Pharmacology of Opiates Flashcards
Two types of opium alkaloids
-Phenanthrenes (morphine, codeine, thebaine)
-Benzylisquinolines (noscapine, papaverine)
-opiATEs are only naturally occuring opioids
Genes for endogenous opioids
-peptides active endogenously
-large precursor proteins cleaved into more opioid subtype selective peptides (precursors)
-degree of redundancy
1. POMC (mu)
2. Preproenkephalin (delta and mu)
3. Prodynoprphin (kappa)
4. Nociceptin/Orphanin FQ (not precursor)
- Pro-opiomelanocortin (POMC)
-B-endorphin -> mu opioid
Preproenkephalin
-Leu-enkephalin -> delta opioid
-Met-enkephalin = mu and delta
Prodynorphin
-dynorphin -> kappa opioid
Nocicceptin Orphanin FQ
not precursor
Types of opioid receptors
-GPCR
-Mu
-Kappa
-Delta
-Nociceptin, orphanin FQ receptor
-sigma (not opioid)
GPCR opioid receptor
-Family A-peptide receptors
-Gi/o (inhibit cAMP)
-open GIRK potassium channels
-close calcium channels
-presynaptic (Gi) = dec NT release
-post-synaptic (GBy) = activate GIRK = efflux of K = hyperpolarization = less firing
Opioid receptor signal transduction
-presynaptic (Gi) = inhibit Ca channel = dec NT release
-post-synaptic (GBy) = activate GIRK (GBy) = efflux of K = hyperpolarization (less firing)
Mu opioid receptor
-think Morphine
-POMC to beta-endorphines (endogenous morphine)
-also met-encephalin precursor?
-use for analgesia, sedation, antitussive
-not as effective for chronic pain
-cancer pain, palliative, PCA
-suppression of cough center in medulla oblongata (codeine)
-help breakthrough pain
-can start dose as soon as pain reemerges
Beta-endorphins
-endogenous morphine
-mu receptor
-pro-opiomelanocortin (POMC) precursor
-component of runner’s high
Opioid induced side effect mostly ON-TARGET effects
-resp depression (brain stem, pre-botzinger complex in medulla)
-constipation (Gi tract)
-Pruritus (SIDE EFFECT NOT ALLERGY)
-addiction
-urinary retention (ADH release)
-N/V (chemoreceptor trigger zone in medulla)
-Miosis (oculomotor nerve (PAG) not mepiridine (anti-cholinergic effects)?
Kappa opioid receptor
-Prodynorphin to Dynorphins (preprodynorphin natural ligand)
-activation is dysphoric, aversive
-potential use for addiction! tx (dec DA release)
-counterbalance mu opioid receptor effects!
-think Ketocyclazocine
Delta opioid receptor
-enkephalins (preproenkephalin) ligand
-more dynamic expression (intracellular, externalized upon chronic stimuli)
-role in hypoxia/ischemia/stroke (hibernation)
-dec anxiety, depression
-tx alcoholism
-relieve hyperalgesia, chronic pain
-side effect siezures
-no FDA approved delta opioids
-think deferins
Opioid site of action
-ventral tegmental area to nucleus accumbens
-slide 15 idk
Depressant DA release (similar to stimulants)
- opioid binds mu receptor
- Gi signaling inhibits NT release
- less GABA to activate GABA-A
- less inhibition of DA neuron activity
- inc DA release
- inc activation of DA receptors
-slide 16
Metabolism of morphine/phenanthrenes
-readily absorbed
-first-pass (25% bioavailability!)
-hepatic
-CYP2D6 and 3A4!!
-genetic differences
-t1/2 inc with liver disease
-Glucuronidation ar 3 and 6
-morphine-6-glucuronide (M6G) still potnet
Morphine/phenanthrene excretion
-Glomerular filtration
-90% excreted in 24h
Active opioid metabolites
-heroin (morphine), codeine (morphine), tramadol (o-desmethyltramadol) = prodrugs
-NOT fentanyl and methadone
-onset/duration influenced by lipophilicity
Lipophilicity
-low lipophilicity = slower BBB crossing = prolonged duration (morphine)
-high lipo = rapid onset = short duration (fentanyl)
CYP3A4
-makes opioids starting with NOR (think FOUR for NOR)
-norhydrocodone, noroxycodone, noroxymorphone
-oxycodone (semi-synthetic) metabolized by CYP3A4 to noroxycodone in liver
CYP2D6 Ultra-rapid metabolizers (UM)
-UM high prevalence
-upto 50% higher plasma concentrations of morphine when given codiene
-higher adverse effects
CYP2D6 poor metabolizers (PMs)
-more common in whites
-no effect from codeine
-same incidence of adverse events